Related Experiment Video
Updated: Apr 25, 2026

08:45
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
1.7K
[Beta-blockers in septic shock: a review].
R S Vela-Vásquez1, I Grigorov-Tzenkov1, J L Aguilar1
1Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Hospital Son LLatzer, Palma de Mallorca, Islas Baleares, España.
Revista Espanola De Anestesiologia Y Reanimacion
|August 26, 2014
Summary
Beta-adrenergic receptor blockers help manage septic shock by controlling heart rate and improving cardiovascular function. Selective beta-1 blockers may offer better outcomes, including reduced mortality, though further research is needed.
Area of Science:
- Critical care medicine
- Pharmacology
- Cardiovascular physiology
Background:
- Septic shock involves high adrenergic stress, leading to adverse cardiovascular and systemic effects.
- This stress can impair tissue perfusion and negatively impact patient outcomes.
- Existing treatments aim to mitigate these effects, but further optimization is needed.
Purpose of the Study:
- To evaluate the efficacy of beta-adrenergic receptor blockade in managing septic shock.
- To assess the impact of beta-blockers on hemodynamic stability and cardiovascular function.
- To compare the effects of selective vs. non-selective beta-blockers in this context.
Main Methods:
- Review of existing literature on beta-adrenergic receptor blockade in septic shock.
- Analysis of hemodynamic parameters and cardiovascular efficiency in patients receiving beta-blockers.
- Comparison of outcomes between selective beta-1 blockers and non-selective agents.
Main Results:
- Beta-adrenergic blockade effectively controls heart rate elevation in septic shock.
- It helps maintain a favorable hemodynamic profile and improves cardiovascular system efficiency.
- Selective beta-1 blockers show potential for better outcomes than non-selective ones, possibly reducing mortality.
Conclusions:
- Beta-adrenergic receptor blockers are beneficial in managing septic shock.
- Selective beta-1 blockers appear more advantageous, warranting further investigation.
- Additional clinical trials are necessary to confirm benefits and define optimal use.

